autism-vaccine link?

That's one, Ivor and you still don't get what you are missing.

On what evidence are you basing the claim that any increase in shingles will increase the rate of severe shingles?

Do you want to guess how many cases of shingles are never reported to anyone because they are not serious? What studies have been done to determine if the increased rate of shingles was really just from increased looking for cases?

People get severe shingles more often as a complication to other medical problems. Combine that with the fact that immunocompromised people get disseminated zoster and now find the evidence that any increase in zoster from lack of the booster effect of exposure to natural cases of varicella will impact the high risk individuals?

Those serious cases of zoster occurred despite the natural boosting. Healthy people getting zoster is not a serious problem. Unhealthy people get zoster because of internal immune system dysfunction, not because of external boosting failure.

Your lack of knowledge about disseminated zoster makes your assessment of the impact of mass vaccinations for varicella inadequate.


Have you found the other error I pointed out that your lack of broad medical knowledge resulted in?
 
Last edited:
Well, look at what we're concerned about. We're not talking about conflict-of-interest, as the direction of the influence would be to give the impression that these choices are in the best interest of the patient.


The conflict of interest would arise if a doctor paid by a pharmaceutical company delivers a talk slanted towards the promotion of that pharmaceutical companies products rather than focussed on the best interests of the patient. The two wouldn't necessarily coincide. For example....

It's not about prescribing antibiotics in order to treat hypertension.


But it might be about prescribing antibiotics when they are not proven to be useful. Or, at least, slanting the treatment of infections towards the use of antibiotics where there may be little evidence that they make any difference.

It's about brand-name recognition in situations where your choice is six-of-one and half-a-dozen-of-another. If there's otherwise nothing to choose between them, and if other physicians make the same choice in the absence of influence, how can this even be said to be harmful?


Wouldn't that depend on whether there is actually nothing to choose between them. For example there may be a hidden influence to prescribe second line antibiotics as first line antibiotics.

And yet here we are making guidelines, writing editorials, performing research, exerting peer-pressure, and considering regulations in order to avoid this influence


That is the aim. And a worthy one. However, are you happy that that result is being achieved? How closely do doctors read these guidelines and adhere to them as opposed to being influenced by pharmaceutical representatives appearing in their surgeries, talking them out to lunch, and presenting and sponsoring CME activities.

I still don't understand why we should force them to do something they don't want to do, in order to get something from them that we shouldn't want from them in the first place.


For the purpose of eliminating the hidden influence whilst preserving the funding.
 
That's one, Ivor and you still don't get what you are missing.

On what evidence are you basing the claim that any increase in shingles will increase the rate of severe shingles?

Straw man.

Do you want to guess how many cases of shingles are never reported to anyone because they are not serious?

Probably about the same number of cases of chickenpox which are never reported to anyone because they are not serious.

What studies have been done to determine if the increased rate of shingles was really just from increased looking for cases?

I haven’t seen any yet.

People get severe shingles more often as a complication to other medical problems. Combine that with the fact that immunocompromised people get disseminated zoster and now find the evidence that any increase in zoster from lack of the booster effect of exposure to natural cases of varicella will impact the high risk individuals?

More straw.

Those serious cases of zoster occurred despite the natural boosting. Healthy people getting zoster is not a serious problem. Unhealthy people get zoster because of internal immune system dysfunction, not because of external boosting failure.

Your lack of knowledge about disseminated zoster makes your assessment of the impact of mass vaccinations for varicella inadequate.

Here we go again. It isn’t my assessment. It is a hypothesis put forward by experts who have estimated exposure to wide-type varicella boosts cell-mediated immunity for ~20 years. It has been shown people exposed to wide-type varicella (such as doctors or mothers looking after children with chickenpox) are at a significantly lower risk of developing shingles.

Have you found the other error I pointed out that your lack of broad medical knowledge resulted in?

No, but I’d imagine it’s regarding influenza vaccination.
 
Okay, I've read through the transcript. It's nice to see actual investigative reporting. :)


Yes, too little of that. :(

The physicians used in the story recognized the importance of independence, and were able to correctly identify situations which were or were not independent.


A valuable lesson for them and hopefully others not caught out in this investigation. It also demonstrated the influence occurs. The question is will it continue to occur after the commotion dies down.

While the producers documented several attempts to work up to influencing the actual presentations, they also showed that those attempts were unsuccessful.


But they also documented several successful attempts.

The producers documented that requirements to ensure independence may have been adequate, but that the requirements were not adhered to through deception. What they didn't get in to is how the College goes about ensuring adherence to their guidelines.


That is probably the key point. Unless the College actually looks to see that the guidelines are being adhered to and to enforce them, this sort of activity by the pharmaceutical companies is likely to continue.

It shows that even though the process failed at two levels - the directors acted in a deceptive manner and the accreditors failed to catch the deception (I could also add that the physicians involved with the institutions partnering with Healthed could/should take some responsibility for their ignorance) - it would have required failure at several more levels (the presenter providing inaccurate or misleading information on the basis of influence...


The influence, in at least one case, was in securing a speaker who the pharmaceutical companies knew supported their view. That view would not necessarily have been the consensus view and would very likey have been slanted towards the use of the pharmaceutical company's products.

...the physician placing undue weight on that information despite notices of sponsorship at the actual presentation and failing to gather additional information, the physician making a recommendation to a patient that would not be made by a physician who was not subject to that influence) before it would have resulted in an action that was not in the patient's best interest.


I suppose we do not have proof at this level, but I imagine that the pharmaceutical companies would monitor the results of their efforts to influence doctors prescribing behaviour. If their monitoring showed they there was no result from their substantial investment, wouldn't they just try harder? In fact, isn't that likely to have already done so and are now reaping the rewards?

Yet most of the people involved (who were not the ones attempting to perpetuate the deception) were disturbed by the revelation (as were you and I).


Well, we will have to hope that their discomfort was felt by others not directly involved in this investigation and that this leads to action being taken by the College to eliminate the influence.

It heartens me to see that we are essentially concerned about an issue of primary prevention (preventing those factors which could eventually adversely affect the patient's best interest) (appropriate given the original topic of this thread :)), rather than secondary or tertiary (identifying when the patient's best interests have already been affected) prevention.


Do we know that patients' best interest have not been affected though? If pharmaceutical companies have influenced the selection of speakers (even if some speakers have been unaware of that fact) and topics, doesn't that slant the information imparted to doctors at these CME activiites towards pharmaceutical treatment of disorders and slant the coverage of topics towards those in which the pharmaceutical companies have an interest and perhaps away from topics that would be of more use to doctors in their management of their patients.

And it shows that our concerns should be directed at the accrediting bodies, as well as increasing the awareness of physicians involved in the parternerships.


The problem is that, if these accrediting bodies and physicians get their house in order and eliminate the hidden influence of the pharmaceutical companies, what further motive would they have for sponsoring CME activities. Doesn't their continued sponsoring of such events suggest to you that the hidden influence is alive and kicking?
 
The conflict of interest would arise if a doctor paid by a pharmaceutical company delivers a talk slanted towards the promotion of that pharmaceutical companies products rather than focussed on the best interests of the patient. The two wouldn't necessarily coincide. For example....

But it might be about prescribing antibiotics when they are not proven to be useful. Or, at least, slanting the treatment of infections towards the use of antibiotics where there may be little evidence that they make any difference.

Wouldn't that depend on whether there is actually nothing to choose between them. For example there may be a hidden influence to prescribe second line antibiotics as first line antibiotics.

I agree those issues are relevant. Another issue is cost.

That is the aim. And a worthy one. However, are you happy that that result is being achieved? How closely do doctors read these guidelines and adhere to them as opposed to being influenced by pharmaceutical representatives appearing in their surgeries, talking them out to lunch, and presenting and sponsoring CME activities.

So as not to make the same mistake again, can you specify what result you are asking about?

For the purpose of eliminating the hidden influence whilst preserving the funding.

How would it eliminate the hidden influence?

Linda
 
<snip>

We were talking about making recommendations on when to use vaccines for the entire society. How does being qualified to follow the recommendations equal being qualified to make the recommendations?

I never said it did.

No, that post had nothing to do with my comments. My comments follow your claim that you know as much as people with expertise in a field, and that the expertise isn't needed, in fact it only serves to bias the expert.

I never claimed to know as much as people with expertise in a field, I claimed you do not have to have expertise in a field to make reasonable decisions about the use of technology from that field, and that experts are more likely to be enthusiastic about the use of a technology they are interested in.

This is a straw man and since I never made such a claim, there is no reason I need to answer this.

Really?

Ivor said:
Skeptigirl said:
There are many times when a lay person's contribution to a group is extremely valuable. That doesn't make their opinion sufficient alone.
How could their contribution be extremely valuable? I thought all the information discussed at an ACIP meeting would be over their heads? What could they know that the experts do not?

So, I ask again: Do you think lay peoples' contributions to the ACIP in the US (or JCVI in the UK) are extremely valuable? If so, how?

If the expert opinions were correct to dismiss the lay person's point, then why should they not do so?

Correctness is not required for an expert to dismiss a non-expert’s point.
 
But they also documented several successful attempts.

I thought I read it carefully, but I must have missed that. Do you remember where in the transcript you saw that?

The influence, in at least one case, was in securing a speaker who the pharmaceutical companies knew supported their view. That view would not necessarily have been the consensus view and would very likey have been slanted towards the use of the pharmaceutical company's products.

I'm not sure that one person's perspective would be assumed to be the consensus view in the first place. But it was also stated that the program was shared by a physician who emphasized non-pharmacological methods.

I suppose we do not have proof at this level, but I imagine that the pharmaceutical companies would monitor the results of their efforts to influence doctors prescribing behaviour. If their monitoring showed they there was no result from their substantial investment, wouldn't they just try harder? In fact, isn't that likely to have already done so and are now reaping the rewards?

The pharmaceutical companies would be looking for increased use of their drugs, whereas we would be more interested in whether the use was appropriate. Simply discovering that sales of a particular drug increased may be sufficient for them, but not for us. It may be that that increase was appropriate (i.e. what's good for them is also good for us).

Do we know that patients' best interest have not been affected though?

That was my attempt at explaining why documenting that pharmaceutical companies suggested particular topics and particular speakers doesn't get you the answer.

The problem is that, if these accrediting bodies and physicians get their house in order and eliminate the hidden influence of the pharmaceutical companies, what further motive would they have for sponsoring CME activities. Doesn't their continued sponsoring of such events suggest to you that the hidden influence is alive and kicking?

Probably the same motive that any business has for sponsoring an event or any other forms of advertising - brand name recognition, good-will. It falls under "marketing" rather than "education" in the budget.

Linda
 
....Here we go again. It isn’t my assessment. It is a hypothesis put forward by experts who have estimated exposure to wide-type varicella boosts cell-mediated immunity for ~20 years. It has been shown people exposed to wide-type varicella (such as doctors or mothers looking after children with chickenpox) are at a significantly lower risk of developing shingles.
What you forget here Ivor is the whole picture. You can't seem to put the bigger picture together. I chalk that up to not having a medical education and years of experience. You don't like my saying that but it is my opinion. If you are going to tout a cost/benefit analysis as evidence, then you are concluding that analysis is correct. In fact, you claim you don't need any special expertise to understand that cost/benefit analysis. But if you had the expertise, you would see where either, the 'expert's' conclusions were faulty or your interpretation of their conclusions is faulty.

Think BIG PICTURE, Ivor. Put all the pieces together. That is what one does with a broad background in something.

The expert hypothesis you have chosen to accept the conclusion of misses a key fact and/or it is you who is trying to combine two separate conclusions and because you don't understand a key fact about zoster, you don't recognize they do not add up as you think. I'm not going to go back over your sources to see which of these two options is the one because it is not relevant. What is relevant is the conclusion misses a key fact, regardless of who is drawing the conclusion.

You are claiming that the costs savings of using varicella vaccine will be offest by an increase in the cost of treating shingles.

Did you or did you not make that claim? Because if you did not make that claim then what is your objection to varicella vaccination?

But you don't understand that shingles and serious complications from shingles, especially disseminated zoster are two separate things. Serious consequences from zoster is dependent on other things being wrong with the person. If you don't know that or the 'experts' making the cost analysis don't know that then you and/or they make the mistake of thinking that an increase in shingles means an increase in serious complications from shingles and therefore an increase in death and medical costs from shingles if varicella vaccine use is recommended for the general population.

Increasing cases of zoster does not increase the population of people with weakened immune systems. So you do not know if increasing cases of zoster will impact the people with the potential for hospitalization and death. It is much more likely that only minor routine cases of zoster will increase.

The reason I say this is because 90% of the population currently gets chicken pox by the age of 20, and most of the rest sometime before the age of 50. So almost the entire adult population already has the latent zoster virus. Those people whose immune systems allow serious zoster recurrences are not currently responding to natural boosting in the first place. So taking away natural boosting will not necessarily have much impact on serious complications and death from zoster.

What is having a serious impact on severe zoster cases is the HIV pandemic. The cost analysis you cited or your interpretation of it is flawed.




No, the other error did not have to do with influenza vaccine. It had to do with you not recognizing that your source of another cost/benefit analysis was only concerned with costs to 3rd party payers. It did not consider the broader cost impact of vaicella which the public health parties such as the ACIP do include in their analysis. Unless you are a medical insurance company or even the persons looking at the single aspect of cost to the national health budget, a narrow look at only some costs is not appropriate in assessing the overall cost/benefit of using varicella vaccine.
 
Linda,

Sorry for the delay - the footy season has started.

So as not to make the same mistake again, can you specify what result you are asking about?


The result aimed at by those guidelines - preventing pharmaceutical companies form exerting influence on medical professionals.

How would it eliminate the hidden influence?


The hidden influence of the pharmaceutical compnaies could be eliminated by eliminating the direct involvement of pharmaceutical companies in CME events. You don't think the levy system is ideologicallly sound, but I think it could be practical solution.
 
But they also documented several successful attempts.
I thought I read it carefully, but I must have missed that. Do you remember where in the transcript you saw that?


The case of the specialist who was selected by the pharmaceutical company to speak at a CME event but was totally unaware of that fact as were the medical practitionere attending the event.
The case of the medical practitioner who was selected by the pharmaceutical company and actually coached in how to present his talk at a CME event. He had what most would consider an unduly optimistic view on the use of Duromine in the treatment of obesity and mentioned the brand name at least six times during his talk. These facts were hidden form the audience
The case of the four CME events on analgesia, sponsored by the manufacturer of Tramal who was able to have a session on migraines included in the seminar and was able to ask for and recieve the attitude of the various speakers towards their drug.

I'm not sure that one person's perspective would be assumed to be the consensus view in the first place. But it was also stated that the program was shared by a physician who emphasized non-pharmacological methods.


Fine, but it is a problem, isn't it, that a speaker is selected who has a view that is slanted towards the pharmaceutical companies products. The use of the second physician was a good move though, yes.

The pharmaceutical companies would be looking for increased use of their drugs, whereas we would be more interested in whether the use was appropriate. Simply discovering that sales of a particular drug increased may be sufficient for them, but not for us. It may be that that increase was appropriate (i.e. what's good for them is also good for us).


But it would be a problem for you, wouldn't it, if the increased sales of their product was not in line with what the evidence says is best practice and if this result was achieved by their sponsorship of CME events where they actually paid for the right to select speakers with views favourable to their product? What is the chance, do you think, that the PCs outcome would coincide with best practise?

That was my attempt at explaining why documenting that pharmaceutical companies suggested particular topics and particular speakers doesn't get you the answer.


But wouldn't it be against the odds that a pharmaceutical companies push to sell it's products by their sponsorship of CME events would coincide with what would be considered best practise. They would be slanting the actual practise towards the use of their products, wouldn't they?

Probably the same motive that any business has for sponsoring an event or any other forms of advertising - brand name recognition, good-will. It falls under "marketing" rather than "education" in the budget.


Yes, and when "marketing" doesn't coincide with "education", who wins the day? Here is an example form a year or so ago:
The evidence apparently suggests that the older much cheaper anti-hypertensive drugs are just as good, if not better, than the newer much dearer alternatives, yet medical practitioners are prescribing the newer much dearer drugs much more frequently than the older cheaper drugs.
I suppose that could have been the result of "brand recognition". The different pharmaceutical companies promoting the recognition of their particular brand of the new anti-hypertensive drugs with the result that all of them are effectively promoting the use of these dearer but no more effective drugs amongst the medical profession.
 
Last edited:
....
The hidden influence of the pharmaceutical compnaies could be eliminated by eliminating the direct involvement of pharmaceutical companies in CME events. You don't think the levy system is ideologicallly sound, but I think it could be practical solution.
Just as an anecdote here, I get free CME wherever it is convenient. But I keep current in my practice by a lot of reading and networking with other providers. And I only view free CME presentations as introductions to information that of course needs further investigation on my part. Just like I use Wiki as a source of citations, it gives you good information if you use it properly.
 
Last edited:
...and I think you polish up on your knowledge by downloading on unfortunates on this forum. :D

Actually, I don't understand how someone can get upset on an internet forum.
Mostly they don't know you and you don't know them and you will probably never meet. So if someone slams you over the head with their superior knowledge, who is actually the winner here. How can it actually hurt to be "hit over the head with knowledge" on an internet forum anyway?

On the other hand, if I ever make it to a TAM meeting, I'm coming with gloves. ;)

regards,
BillyJoe
 
Last edited:
...and I think you polish up on your knowledge by downloading on unfortunates on this forum. :D

Actually, I don't understand how someone can get upset on an internet forum.
Mostly they don't know you and you don't know them and you will probably never meet. So if someone slams you over the head with their superior knowledge, who is actually the winner here. How can it actually hurt to be "hit over the head with knowledge" on an internet forum anyway?

On the other hand, if I ever make it to a TAM meeting, I'm coming with gloves. ;)

regards,
BillyJoe

I often wonder if the people I interact with most on this forum behave in a similar way face to face.
 
I'm nice in person. I just lose patience in some of these discussions when the answer to fully make one's case might include a couple pages of background information and there is little hope that without the background information the other person is going to understand.

In your case, however, Ivor, sometimes you just refuse to look at the other person's posts in an open minded way. And I do look at yours with an open mind and try to actually address what you bring up. In return, you seem to just dig your heels in further and that gets tiring.

There is a point where in a discussion with you it comes down to different values and I have no problem saying there is no right or wrong when it is simply a difference in values. But when someone provides supporting material in their field of expertise, and it is not my field of expertise (such as the cosmology thread), then I am going to take a pretty careful look at that material before I start spouting my mouth off that one does not need that expertise to understand the problem.
 
Last edited:
I already thought you were a nice person. I don't think you're necessarily wrong. I think you're overconfident regarding this particular issue, just as I thing Linda is overconfident in the effectiveness of self-regulation of medical professionals.
 
Excuse me, I have been lurking here for a few pages, but does any of this have to do with autism and the bogus assertion that there is a link between autism and vaccination.

Also Ivor, do you know that many many old people get shingles as a result of the aging of thier immune system?
 
Excuse me, I have been lurking here for a few pages, but does any of this have to do with autism and the bogus assertion that there is a link between autism and vaccination.

Given that people who buy into the autism-vaccine link probably don't entirely trust the medical profession, quite a lot.

Also Ivor, do you know that many many old people get shingles as a result of the aging of thier immune system?

Yes. There's a good article on shingles here, and one on varicella here.
 
Linda,

Sorry for the delay - the footy season has started.

I guess I'm supposed to know what that means.

The result aimed at by those guidelines - preventing pharmaceutical companies form exerting influence on medical professionals.

These are examples of things which serve to favour my satisfaction with the process:

Surveys such as the one referenced by Ivor earlier that show a very high commitment to professionalism and that behaviour follows from that attitude.*

Guidelines that are increasingly restrictive.

Increasing recognition of the role of influence through research and education.

Presentation of published research in a manner that encourages concern, rather than complacency.

Top-down dissemination of knowledge and attitudes from professional organizations, academic medical centres, regulatory bodies, etc.

Research that consistently shows that physicians will change behaviour in response to evidence.

Examples of the results of influence which cannot be demonstrated to not be in the patient's best interest (more on that in the next post).

Examples of things which defeat the process:

Resistance to the recognition of personal susceptibility to influence among physicians.**

Huge disparity in resources dedicated to the task between pharmaceutical companies (dedicated to influence) and healthcare workers (dedicated to resisting influence).

In the US, lack of commitment on the part of legislators to back-up efforts made by professional organizations.

Overall, I am reasonably confident that the direction we continue to move when it comes to knowledge/attitude/behaviour will ensure that this does not develop into a demonstrable problem.***

The hidden influence of the pharmaceutical compnaies could be eliminated by eliminating the direct involvement of pharmaceutical companies in CME events. You don't think the levy system is ideologicallly sound, but I think it could be practical solution.

But how would that change what happens now? Wouldn't there still be incentive for them to be a bit sneaky about influencing healthcare workers? Unless you are talking about forbidding advertising when it comes to pharmaceuticals - just the sort of anti-capitalist, anti-innovation propaganda I'd expect from those commie-universal-health-care proponents.

Linda

*I realize that the survey was presented as though it said something different on the Overcoming Bias site. But I suspect that this reflects one of those characteristics that helps gives me some confidence - that the authors over-emphasized results suggesting that we fall short of the ideal, rather than encouraging complacency by confirming that for the most part we conform to the ideal.

**I don't know if physicians as a group are more prone to this (I admit that my impression that they are is not based on any specific evidence), or whether it simply reflects the underlying characteristics of the group (for example, smart people tend to be better at rationalizing their actions and physicians tend to be smart).

***By 'demonstrable problem' I mean impacts on the outcomes of death, disability, and disease, and somewhat discomfort and dissatisfaction. There are other outcomes, such as cost, that are reasonable concerns.
 

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom